Agoracom: Small Cap Investment - Mannkind - Re: Shkreli Letter

Welcome To The Mannkind HUB On AGORACOM

Edit this title from the Fast Facts Section

Reply New Message

Prev Message Back To Forum Threaded View Next Message

CaliMann

Rank: Mail Room [?]

Points: 75 [?]

Votes: 3 Score: 2.3 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Shkreli Letter - chmith27 Med Input

in response to

Re: Shkreli Letter - chmith27 Med Input

opc

posted on Aug 19, 2012 05:15PM

http://seekingalpha.com/article/247695-mannkind-s-path-forward

Seems to be a clear explanation as to the clinical utility problems Mannkind faced.

However, i did not see if there were seperate issues as to the clinical utility other than the

bioequivalcy data pointed out in the artical.

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply